Noticed that this sausage skin maker reported yesterday. Good results, low debt and dividend yield of 8%. Looks tasty to me so I bought some more shares yesterday. Anyone else investing in this company? I heard rumours about a group called Acomita building a stake - anyone know what's happened to them?
TIA

Another solid set of results imo. Margin improvement expected from price increases due this year, so 2013 should not disappoint. Pension deficit might become an issue, but holding mine for the longer term. Always dyor.

May have some effect.

Processed meat 'early death' link

Sausages, ham, bacon and other processed meats appear to increase the risk of dying young, a study of half a million people across Europe suggests.

As of Mar 15, 2013, the consensus forecast amongst 7 polled investment analysts covering Devro plc advises that the company will outperform the market. This has been the consensus forecast since the sentiment of investment analysts improved on Nov 23, 2012. The previous consensus forecast advised investors to hold their position in Devro plc.


Ex-dividend Wednesday 27 March - 5.85p

Nice and steady

2013 Interim Results

About what was expected. Pleased no further bad news and management now has to show it can deliver in the second half. Still a number of potential obstacles (availability of raw materials, new plant coming on stream etc) but happy to give them the benefit of the doubt for the time being. Always dyor.

Punished after results this week - sell in Ukraine/Russia, cuurency headwinds and funding for cap ex on expansion into China yet to be finalised. Cash generation still strong and modest increase in dividend a sign of management confidence, which does not seem to be shared by the market. I will give them the benefit of the doubt, but always dyor.

RESULTS FOR THE YEAR ENDED 31 DECEMBER 2014

Transformation on track to support future growth

Devro plc ("Devro" or the "Group"), one of the world's leading manufacturers of collagen products for the food industry, is pleased to announce its results for the year ended 31 December 2014.


Operational highlights
· Performance was in line with expectations
· Sales volumes have shown steady recovery since end of first quarter and revenue for the year grew by 2% in constant currency*
· Operating profit before exceptional items lower than prior year primarily due to actions taken to restructure the business reducing profits by £6.6 million and adverse foreign exchange movements of £4.3 million
· Strong cash generation with operating cash flow before exceptional items up by 10% as inventory levels reduced following actions taken to manage production capacity together with improved sales

Strategic highlights
· Sales continue to grow in the strategically important markets of China, Japan and Germany, with China sales already at 50% of new plant capacity
· Three year programme to transform the manufacturing footprint is progressing to plan
- Investment projects for new plants in China and USA on track to commence production in 2016
- First phase of restructuring of operations in Scotland now complete
- Restructuring of operations in Australia now implemented
- Restructuring actions on track to deliver annual cost reductions of £5 million from early 2015
· Exceptional items relate to this transformation and are in line with previous guidance